rs56875953
Variant summary
Our verdict is Benign. The variant received -15 ACMG points: 0P and 15B. BP4_ModerateBP6_Very_StrongBP7BS2
The NM_021098.3(CACNA1H):c.1983G>A(p.Pro661Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000618 in 1,503,902 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_021098.3 synonymous
Scores
Clinical Significance
Conservation
Publications
- hyperaldosteronism, familial, type IVInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- childhood absence epilepsyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- epilepsy, childhood absence, susceptibility to, 6Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -15 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA1H | ENST00000348261.11 | c.1983G>A | p.Pro661Pro | synonymous_variant | Exon 9 of 35 | 1 | NM_021098.3 | ENSP00000334198.7 | ||
CACNA1H | ENST00000569107.6 | c.1983G>A | p.Pro661Pro | synonymous_variant | Exon 9 of 34 | 1 | ENSP00000454990.2 | |||
CACNA1H | ENST00000711493.1 | c.1983G>A | p.Pro661Pro | synonymous_variant | Exon 9 of 34 | ENSP00000518778.1 | ||||
CACNA1H | ENST00000565831.7 | c.1983G>A | p.Pro661Pro | synonymous_variant | Exon 9 of 34 | 1 | ENSP00000455840.1 | |||
CACNA1H | ENST00000711450.1 | c.1983G>A | p.Pro661Pro | synonymous_variant | Exon 9 of 35 | ENSP00000518762.1 | ||||
CACNA1H | ENST00000564231.6 | c.1983G>A | p.Pro661Pro | synonymous_variant | Exon 9 of 35 | 1 | ENSP00000457555.2 | |||
CACNA1H | ENST00000638323.1 | c.1944G>A | p.Pro648Pro | synonymous_variant | Exon 9 of 35 | 5 | ENSP00000492267.1 | |||
CACNA1H | ENST00000562079.6 | c.1983G>A | p.Pro661Pro | synonymous_variant | Exon 9 of 34 | 1 | ENSP00000454581.2 | |||
CACNA1H | ENST00000711438.1 | c.1944G>A | p.Pro648Pro | synonymous_variant | Exon 9 of 34 | ENSP00000518754.1 | ||||
CACNA1H | ENST00000711482.1 | c.1983G>A | p.Pro661Pro | synonymous_variant | Exon 9 of 36 | ENSP00000518771.1 | ||||
CACNA1H | ENST00000711485.1 | c.1983G>A | p.Pro661Pro | synonymous_variant | Exon 9 of 35 | ENSP00000518774.1 | ||||
CACNA1H | ENST00000711455.1 | c.1983G>A | p.Pro661Pro | synonymous_variant | Exon 9 of 36 | ENSP00000518768.1 | ||||
CACNA1H | ENST00000711483.1 | c.1983G>A | p.Pro661Pro | synonymous_variant | Exon 9 of 35 | ENSP00000518772.1 | ||||
CACNA1H | ENST00000711456.1 | c.1983G>A | p.Pro661Pro | synonymous_variant | Exon 9 of 34 | ENSP00000518769.1 | ||||
CACNA1H | ENST00000621827.2 | n.1983G>A | non_coding_transcript_exon_variant | Exon 9 of 37 | 6 | ENSP00000518766.1 | ||||
CACNA1H | ENST00000637236.3 | n.1983G>A | non_coding_transcript_exon_variant | Exon 9 of 34 | 5 | ENSP00000492650.2 | ||||
CACNA1H | ENST00000639478.1 | n.1983G>A | non_coding_transcript_exon_variant | Exon 9 of 35 | 5 | ENSP00000491945.1 | ||||
CACNA1H | ENST00000711442.1 | n.*1430G>A | non_coding_transcript_exon_variant | Exon 8 of 34 | ENSP00000518758.1 | |||||
CACNA1H | ENST00000711448.1 | n.1983G>A | non_coding_transcript_exon_variant | Exon 9 of 36 | ENSP00000518760.1 | |||||
CACNA1H | ENST00000711449.1 | n.1983G>A | non_coding_transcript_exon_variant | Exon 9 of 35 | ENSP00000518761.1 | |||||
CACNA1H | ENST00000711451.1 | n.1983G>A | non_coding_transcript_exon_variant | Exon 9 of 36 | ENSP00000518763.1 | |||||
CACNA1H | ENST00000711452.1 | n.1983G>A | non_coding_transcript_exon_variant | Exon 9 of 36 | ENSP00000518764.1 | |||||
CACNA1H | ENST00000711453.1 | n.1983G>A | non_coding_transcript_exon_variant | Exon 9 of 36 | ENSP00000518765.1 | |||||
CACNA1H | ENST00000711484.1 | n.1983G>A | non_coding_transcript_exon_variant | Exon 9 of 35 | ENSP00000518773.1 | |||||
CACNA1H | ENST00000711486.1 | n.1983G>A | non_coding_transcript_exon_variant | Exon 9 of 37 | ENSP00000518775.1 | |||||
CACNA1H | ENST00000711487.1 | n.1983G>A | non_coding_transcript_exon_variant | Exon 9 of 36 | ENSP00000518776.1 | |||||
CACNA1H | ENST00000711488.1 | n.1983G>A | non_coding_transcript_exon_variant | Exon 9 of 35 | ENSP00000518777.1 | |||||
CACNA1H | ENST00000711442.1 | n.*1430G>A | 3_prime_UTR_variant | Exon 8 of 34 | ENSP00000518758.1 | |||||
CACNA1H | ENST00000640028.1 | n.1385+598G>A | intron_variant | Intron 9 of 34 | 5 | ENSP00000491488.1 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152220Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000435 AC: 5AN: 114840 AF XY: 0.0000329 show subpopulations
GnomAD4 exome AF: 0.0000629 AC: 85AN: 1351682Hom.: 0 Cov.: 38 AF XY: 0.0000545 AC XY: 36AN XY: 660664 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152220Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74362 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Inborn genetic diseases Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at